Search for: "State v. Tri-State Pharmaceutical"
Results 141 - 160
of 456
Sorted by Relevance
|
Sort by Date
18 Jul 2014, 11:55 am
Wyeth Pharmaceuticals, Inc., 2008 WL 7136137 (Ala. [read post]
26 Aug 2011, 8:02 am
Plaintiff next tried to argue differential diagnosis. [read post]
27 Jun 2019, 6:33 am
The case concerned two giants of the bio-pharmaceuticals world, Roche and Pfizer, and Roche's blockbuster biologic, Avastin. [read post]
21 Dec 2012, 11:41 am
State v. [read post]
3 Aug 2020, 6:56 am
Another empirical test of Beshada’s fairness occurred in a state court case tried before the Hon. [read post]
12 Nov 2009, 9:17 am
TriNessa (Tri-Cyclen) non-personal injury case. [read post]
21 May 2007, 4:43 pm
Industrial Co. v. [read post]
2 Feb 2012, 7:30 pm
In Fredericks v. [read post]
1 Mar 2011, 10:13 am
Board of Trustees of Leland Stanford Junior University v. [read post]
30 Jul 2013, 2:53 pm
One such case is Generics [UK] Ltd (t/a Mylan) v Yeda Research And Development Co Ltd and Teva Pharmaceutical Industries Ltd [2013] EWCA Civ 925, decided yesterday by a three-man Court of Appeal for England and Wales which consisted of two specialist IP judges -- Lords Justices Kitchin and Floyd -- together with Lord Justice Moses. [read post]
27 Nov 2012, 8:43 am
A finding of infringement is a finding that a monopoly granted by the state is to be enforced. [read post]
29 Aug 2014, 11:14 am
The case is Sanchez v. [read post]
23 Nov 2015, 8:59 am
One straw that generic drug plaintiffs have grasped at is the footnote in Mutual Pharmaceutical Co. v. [read post]
21 Dec 2017, 5:00 am
Janssen Pharmaceuticals, 2017 Pa. [read post]
3 Aug 2023, 10:48 am
See Phillips v. [read post]
22 May 2014, 5:00 am
In Touhy, a convict tried to subpoena an FBI agent in the course of his habeas corpus petition. [read post]
31 Dec 2015, 5:12 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., ___ F.3d ___, 2015 WL 8538119 (6th Cir. [read post]
24 Apr 2017, 11:12 am
Amgen and Amgen v. [read post]
26 Dec 2011, 12:37 pm
In Polk v. [read post]
22 Jan 2015, 9:56 pm
(and several other firms), tried to market a generic version of Copaxone. [read post]